AI-powered smartphone app to help teens and young adults quit e-cigarettes
AI-Enhanced App-based Intervention for Adolescent E-cigarette Cessation
An AI-powered smartphone app will deliver personalized messages and support to help adolescents and young adults stop using e-cigarettes.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | State University of New York at Buffalo NIH-funded |
| Lab location | 1 site (Amherst, United States) |
| Project ID | NIH-11181635 on NIH RePORTER |
What this research studies
If I join, I'll use a smartphone app that uses AI to tailor messages based on my vaping patterns, other substance use, readiness to quit, and beliefs about e-cigarettes. The app will send personalized tips, reminders, and support and is designed to be scalable so schools, clinics, or community programs can use it. The research team will test launching the AI-enhanced app, refine its personalized messaging, and check how easy it is for teens and young adults to use. Participation likely involves answering questions about vaping, receiving tailored messages, and brief app-based check-ins.
Who could benefit from this research
Good fit: Ideal candidates are adolescents and young adults who currently use e-cigarettes, want help quitting, and have regular access to a smartphone.
Not a fit: People who do not use e-cigarettes, are not ready to quit, lack a smartphone, or need prescription medications for nicotine withdrawal are unlikely to benefit directly from this app alone.
Why it matters
Potential benefit: If successful, the app could make it easier for many teens and young adults to quit e-cigarettes by providing regular, personalized quitting support.
How similar studies have performed: Some digital smoking-cessation programs have shown promise, but AI-personalized apps specifically targeting adolescent e-cigarette cessation are relatively new and not yet widely proven.
Where this research is happening
Amherst, United States
- State University of New York at Buffalo — Amherst, United States (Active)
Researchers
- Principal investigator: Park, Eunhee — State University of New York at Buffalo
- Study coordinator: Park, Eunhee
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.